stockrow
Saturday 31 October 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRA Real Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024. In the quarter to June 2026, revenue grew 24.7%, EPS fell 135.7%, free cash flow fell 666.1% and total debt rose 5.91%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.
19.74
0.13
+0.66%
Follow SBRA
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 5 | 6 | 4 |
| 6.28% | 5.59% | 5.69% | 2.40% | ||
| 3.20% | 2.88% | 2.89% | 1.21% | ||
ROIC |
3.12% | 3.04% | 3.01% | 1.91% | |
Return on Tangible Assets |
3.40% | 3.06% | 3.04% | 1.29% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.31 | (0.24) | (0.52) | (1.10) | |
Free Cash Flow |
74.23 | (57.20) | (131.42) | (277.23) | |
Capital Expenditures |
(266.93) | (405.82) | (498.13) | (648.80) | |
| Other line items | |||||
Cash ROIC |
1.32% | (1.05%) | (2.36%) | (4.94%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.01) | (0.01) | (0.01) | (0.04) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.82% | 6.93% | 6.87% | 7.00% | |
Share Based Compensation of Revenue |
1.45% | 1.47% | 1.45% | 1.53% | |
Interest Coverage |
2.33 | 2.28 | 2.26 | 1.35 | |
Operating CF/Net income |
1.95 | 2.24 | 2.35 | 5.68 | |
Depreciation/Fixed assets |
0.04 | 0.04 | 0.04 | 0.04 | |
Capex/Depreciation |
(1.50) | (2.17) | (2.53) | (3.10) | |
Revenue per Share |
3.11 | 3.21 | 3.22 | 3.41 | |
Operating CF per Share |
1.42 | 1.44 | 1.45 | 1.47 | |
Capex per Share |
(1.11) | (1.68) | (1.98) | (2.57) | |
Capex to Sales |
0.36 | 0.52 | 0.61 | 0.75 |
Columns are period end dates